Team:
- Jeffrey Goffman – Chairman & CEO
- Grant Ingersoll – SVP & Chief Development Officer
- David Crowley – SVP & Chief Financial Officer
- Mark Lama – SVP & Chief Operating Officer
- Michael McEnery – Director of Operations – Southern California
- Nicki McKnight, CPC, CHC – Director of Compliance
Jeffrey Goffman - Chairman & CEO
Jeffrey Goffman is the Chairman, CEO and Co-Founder of Integrated Oncology Network, LLC in 2009. Mr. Goffman was the Founder of OnCURE Medical Corp. (“OnCURE”). From 1998 until 2007 Mr. Goffman held various positions during his tenure at OnCURE including President, CEO and COO. OnCURE is one of the largest providers of outpatient radiation oncology care in the United States. OnCURE’s investors during Mr. Goffman’s leadership included Crossbow Ventures, Mercurius Fund, MedEquity, Halpern Denny & Co., Genstar Capital, Ares Management and Caisse de Dupot. Mr. Goffman grew OnCURE from its inception in 1998 to over $120 million in revenues with $32 million in EBITDA with 40 centers owned and managed with a regional focus (number one provider in the State of California and the number two provider in the State of Florida) and approximately 100 oncologists affiliate with its centers.
Mr. Goffman is also a co-founder, investor and serves on the Board of Directors of Affiliated Pet Systems, LLC, a private company that provides Positron Emission Tomography services in the Maryland / Washington D.C. area.
Mr. Goffman was the founder of U.S. Diagnostic, Inc. (“USD”), a leading consolidator of outpatient diagnostic imaging facilities. From its inception in June 1993 until 1997, Mr. Goffman served as USD’s Chairman and Chief Executive Officer, and took USD public in 1994. While at USD, Mr. Goffman grew USD to 120 centers in 19 states and over $225 million in revenues.
In 1988 Mr. Goffman founded Goffman and Associates, Certified Public Accountants, PC, an accounting firm in New York, and remained a partner at this firm until 1994.
Mr. Goffman is an inactive Certified Public Accountant licensed in New York and Florida and holds a Bachelor of Science degree in Accounting from the Barney School of Business at the University of Hartford. Mr. Goffman is a member of the American Institute of Certified Public Accountants. Mr. Goffman is a member of the American Cancer Society’s CEO’s Against Cancer and the former Chair of the Orange County Regional Council. Mr. Goffman is also a Board Member of CureDuchenne.
Grant Ingersoll – SVP & Chief Development Officer
Mr. Ingersoll is the SVP, Chief Development Officer and Co-Founder of Integrated Oncology Network, LLC. Prior to ION, Mr. Ingersoll was the Director of Corporate Development at Vantage Oncology and OnCURE Medical Corp., two of the largest radiation oncology providers in the US. Mr. Ingersoll has also worked at Microsoft, in investment banking at UBS and as a management consultant at Wipro working with Fortune 500 companies around the globe. Mr Ingersoll received his Masters of Business Administration from the University of Southern California and his Bachelor's in Finance from Brigham Young University.
read document
Mark Lama – SVP & Chief Operating Officer
Mr. Lama is the Chief Operating Officer of ION. Mr. Lama has extensive experience in healthcare middle market investments, acquisitions and operations. Mr. Lama was most recently COO of NationsHealth, a medical supplies company focused on diabetes products and insurance services, where he led restructuring efforts on behalf of the ComVest Group. He was also an Operating and Investment Partner at ComVest, a private equity firm focused on middle market acquisitions, where he was a leader of their healthcare investment efforts. Prior to his affiliation with ComVest, Mr. Lama was a Partner at Crossbow Ventures, where he focused on improving and monetizing the value of select portfolio investments. Crossbow Ventures was an investor with Mr. Goffman at OnCURE and Mr. Lama worked with Mr. Goffman on several initiatives. Mr. Lama spent six years as a Principal at UBS Capital Americas private equity group where he originated, led, and managed numerous private equity investments. Prior to this, he spent five years at Chase Capital Partners private equity group, where he worked on over 30 transactions (assisting in over $100 million of investments made by Chase). Mr. Lama received his MBA from Harvard Business School, a Bachelor of Science degree in mechanical engineering from Columbia University, and a Bachelor of Arts degree in physics from Colgate University.
David Crowley – SVP & Chief Financial Officer
David Crowley is the Chief Financial Officer of ION. Previously, Mr. Crowley was the Vice President, Controller of OnCURE Medical Corp. from 2002 to 2009. During his tenure at OnCURE, Mr. Crowley was partially responsible for the accounting department activities for: acquisition integration; post acquisition operational efficiencies; acquisition due diligence; physician reporting; treasury functions; capital request analysis; GL & financial statement preparation; and coordination of all audit and tax work with outside auditors. From 1988 to 2001 Mr. Crowley held various financial and operational positions at Maxicare Health Plans, Inc. (a National HMO with $800 million in revenues and in 29 states) including Assistant Vice President of Underwriting, Assistant VP Accounting Operations and Assistant VP Financial Accounting. Mr. Crowley worked in public accounting prior to joining Maxicare as an audit supervisor at Laventhal & Horvath, CPA’s. Mr. Crowley is an inactive Certified Public Account licensed in California and holds a Bachelor of Business Administration Degree in Accounting from the University of Notre Dame.
Michael McEnery – Director of Development
Mike is the head of Southern California operations for ION. Mike was previously with OnCURE Medical from 2002 until 2007 as part of Mr. Goffman’s team as a Sr. Financial Analyst working in the areas of finance, acquisition, and physician relations.
Previously Mike worked at Celestica (A $600 Million regional contract electronics manufacturer) as a financial analyst, IPC Communication Services (a $120 Million international printing, CD-ROM & DVD manufacturing, software packaging & distribution company) as an assistant controller.
Nicki McKnight, CPC, CHC – Director of Compliance
Nicki McKnight, CPC, CHC is the Director of Compliance for Integrated Oncology Network, LLC. Prior to ION, Ms. McKnight was the Director of Compliance for Vantage Oncology and OnCure Medical Corp., two of the largest oncology providers in the US. Ms. McKnight has also worked for Medicare, training auditors and assisting with investigations and as owner and Chief Operations Officer for OnSite Medical Corp., performing billing and collection services for physicians. Ms. McKnight has a Bachelor’s Degree from Weber State University, is Board Certified in Health Care Compliance through Health Care Compliance Association and is a Certified Professional Coder.
